Nehra et al., 2013 - Google Patents
Is epilepsy a cause of cognitive decline in developing brainNehra et al., 2013
View PDF- Document ID
- 1054997512190866051
- Author
- Nehra A
- Tripathi M
- Bhatia R
- Srivastava M
- Singh M
- Chopra S
- Kaur H
- Bajpai S
- Publication year
- Publication venue
- Activitas Nervosa Superior
External Links
Snippet
Epilepsy is a chronic noncommunicable disorder of the brain that affects people of all ages. Around 50 million people worldwide have epilepsy (WHO, 2012). 45,000 children under the age of 15, develop epilepsy each year (Epilepsy Foundation, 2010). Lower income was …
- 206010015037 Epilepsy 0 title abstract description 58
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state
- A61B5/168—Evaluating attention deficit, hyperactivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghielen et al. | The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson's disease and Huntington's disease: Two meta-analyses | |
Ramanan et al. | Longitudinal executive function and episodic memory profiles in behavioral-variant frontotemporal dementia and Alzheimer’s disease | |
Butler et al. | The syndrome of transient epileptic amnesia | |
Rentz et al. | Association of digital clock drawing with PET amyloid and tau pathology in normal older adults | |
Stamps et al. | A brief olfactory test for Alzheimer's disease | |
Wang et al. | Neuropsychological performance and seizure-related risk factors in patients with temporal lobe epilepsy: a retrospective cross-sectional study | |
Consonni et al. | The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria | |
Samarasekera et al. | Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition | |
Schwartz et al. | The NEO-FFI in multiple sclerosis: internal consistency, factorial validity, and correspondence between self and informant reports | |
Wood et al. | Fifty percent prevalence of extracampine hallucinations in Parkinson’s disease patients | |
Gujral et al. | Course of cognitive impairment following attempted suicide in older adults | |
Rosca et al. | Montreal cognitive assessment for evaluating cognitive impairment in multiple sclerosis: a systematic review | |
Martín et al. | Relevance of the serial position effect in the differential diagnosis of mild cognitive impairment, Alzheimer-type dementia, and normal ageing | |
Giovagnoli | Awareness, overestimation, and underestimation of cognitive functions in epilepsy | |
Malek-Ahmadi et al. | Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment | |
Savage et al. | On the nose: Olfactory disturbances in patients with transient epileptic amnesia | |
Liik et al. | Subjective complaints compared to the results of neuropsychological assessment in patients with epilepsy: The influence of comorbid depression | |
Rosca et al. | Montreal cognitive assessment for evaluating cognitive impairment in Huntington’s disease: a systematic review | |
Jammula et al. | Effects of cognitive reserve on cognition in individuals with central nervous system disease | |
Arnett et al. | Multiple sclerosis and demyelinating disorders. | |
Bakirtzis et al. | Cognitive fatigability is independent of subjective cognitive fatigue and mood in multiple sclerosis | |
de Filippis et al. | Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile | |
Walterfang et al. | Utility and validity of a brief cognitive assessment tool in patients with epileptic and nonepileptic seizures | |
Nehra et al. | Is epilepsy a cause of cognitive decline in developing brain | |
Baker et al. | How can cognitive status predispose to psychological impairment? |